loading page

NOVEL BRIDGE MULTI-SPECIES ELISA FOR DETECTION OF SARS-COV-2 ANTIBODIES EMPLOYING SPIKE PROTEIN AS THE UNIQUE ANTIGEN
  • +10
  • Aldana Trabucchi,
  • Silvina Bombicino,
  • Juan Marfia,
  • Adriana Sabljic,
  • Ruben Iacono,
  • Ignacio Smith,
  • Gregorio Mc Callum,
  • Alexandra Targovnik,
  • Federico Wolman,
  • Matías Fingermann,
  • Leonardo Alonso,
  • Maria Miranda,
  • Silvina Valdez
Aldana Trabucchi
Universidad de Buenos Aires
Author Profile
Silvina Bombicino
Universidad de Buenos Aires
Author Profile
Juan Marfia
Universidad de Buenos Aires
Author Profile
Adriana Sabljic
Universidad de Buenos Aires
Author Profile
Ruben Iacono
Universidad de Buenos Aires
Author Profile
Ignacio Smith
Universidad de Buenos Aires
Author Profile
Gregorio Mc Callum
Universidad de Buenos Aires
Author Profile
Alexandra Targovnik
Universidad de Buenos Aires
Author Profile
Federico Wolman
Universidad de Buenos Aires
Author Profile
Matías Fingermann
Administración Nacional de Laboratorios e Institutos de Salud Dr Carlos G Malbrán
Author Profile
Leonardo Alonso
Universidad de Buenos Aires
Author Profile
Maria Miranda
Universidad de Buenos Aires Facultad de Farmacia y Bioquimica
Author Profile
Silvina Valdez
Universidad de Buenos Aires

Corresponding Author:silval@ffyb.uba.ar

Author Profile

Abstract

Background Considering the course of the current SARS CoV 2 pandemic, it is important to have serological tests for the detection of the anti-SARS CoV-2 humoral immune response for monitoring and prognosis the different stages of the disease. Purpose Herein we describe a novel bridge enzyme-linked immunosorbent assay (b-ELISA) for SARS-CoV-2 antibodies detection in human and other species, employing recombinant Spike protein as a unique antigen, which is produced at high scale in insect larvae. Results Eighty two human control sera/plasmas and 169 COVID-19 patients’ sera/plasmas, confirmed by rRT-PCR, were analysed by the b-ELISA assay. Out of the 169 patient samples, 129 were positive for IgG anti-SARS-CoV-2 and 40 were negative when they were tested by ELISA COVIDAR® IgG. When a cut-off value of 5.0 SDs was established, 124 out of the 129 COVID-19 positive samples were also positive by our developed b-ELISA (sensitivity: 96.12%). A total of 27 animal sera (5 horses, 13 rats, 2 cats and 7 dogs) were employed in order to evaluate the b-ELISA in other animal species. Conclusion The obtained results demonstrate that the method developed herein is versatile, as it is able to detect antibodies anti-SARS-CoV-2 in different animal species without the need to perform and optimize a new assay for each species.